EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of Spirulina platensis Supplementation on COVID-19 Severity in Critically Ill Patients: A Randomized Clinical Trial

Mahdi Shadnoush, Heitor O. Santos, Monireh Hatami, Mehdi Norouzi, Mohsen Taghavi, Henrique Santa Capita Cerqueira, Mansoore Sadat Mojani- Qomi, Hooman Bakhshandeh, Jamal Rahmani, Zainab Javid, Davood Sanaei Delir Zavaragh, Fatemeh Mikaniki und 3 weitere

Journal of Cellular and Molecular Anesthesia · 2024

DOI: 10.5812/jcma-149015 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cellular and Molecular Anesthesia, 2024. Verfasst von Mahdi Shadnoush und 14 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spirulina is a functional food with antioxidant and anti-inflammatory properties. Its anti-inflammatory, antioxidant, antiviral, and immunomodulatory potential may improve certain clinical conditions in patients with coronavirus disease 2019 (COVID-19) in the intensive care unit (ICU).

Objectives

This study aimed to investigate the effects of Spirulina supplementation on clinical conditions in critically ill patients with COVID-19.

Methods

A double-blind clinical trial randomized patients admitted to an ICU to receive either Spirulina platensis supplementation (5g/day, n = 97) or to a control group (n = 95). The severity of COVID-19 was assessed using the Acute Physiology and Chronic Health Evaluation (APACHE), National Early Warning Score (NEWS) 2, and Sequential Organ Failure Assessment Score (SOFA). The study also evaluated the length of stay in the hospital and ICU, respiratory support at discharge, and 28-day mortality. In the survival analysis, 126 participants were evaluated (58 in the control group and 68 in the Spirulina group).

Results

There was no significant difference between the groups in 28-day mortality (HR = 1.07, 95% CI 0.57 - 1.97) or NEWS2 (P = 0.76). However, the SOFA score significantly decreased in the Spirulina group compared to the control group (P = 0.03). The Spirulina group had a shorter ICU length of stay (7.43 ± 3.98 days) compared to the control group (10.00 ± 4.69 days, P = 0.007). The hospital length of stay was also shorter in the Spirulina group compared to the control group (P = 0.001).

Conclusions

Spirulina supplementation reduced disease severity (as measured by the SOFA score) and shortened hospital and ICU length of stay in critically ill COVID-19 patients, but it did not reduce mortality.

Zitieren

APA

Shadnoush, M., Santos, H. O., Hatami, M., Norouzi, M., Taghavi, M., Cerqueira, H. S. C., Qomi, M. S. M., Bakhshandeh, H., Rahmani, J., Javid, Z., Zavaragh, D. S. D., Mikaniki, F., Chaharmahali, A., Ghanavati, M., & Nazari, M. (2024). Effects of Spirulina platensis Supplementation on COVID-19 Severity in Critically Ill Patients: A Randomized Clinical Trial. Journal of Cellular and Molecular Anesthesia. https://doi.org/10.5812/jcma-149015

Vancouver

Shadnoush M, Santos HO, Hatami M, Norouzi M, Taghavi M, Cerqueira HSC, et al. Effects of Spirulina platensis Supplementation on COVID-19 Severity in Critically Ill Patients: A Randomized Clinical Trial. Journal of Cellular and Molecular Anesthesia. 2024. doi:10.5812/jcma-149015

BibTeX
@article{Shadnoush2024,
  author = {Shadnoush, Mahdi and Santos, Heitor O. and Hatami, Monireh and Norouzi, Mehdi and Taghavi, Mohsen and Cerqueira, Henrique Santa Capita and Qomi, Mansoore Sadat Mojani- and Bakhshandeh, Hooman and Rahmani, Jamal and Javid, Zainab and Zavaragh, Davood Sanaei Delir and Mikaniki, Fatemeh and Chaharmahali, Arezoo and Ghanavati, Matin and Nazari, Mojgan},
  title = {Effects of Spirulina platensis Supplementation on COVID-19 Severity in Critically Ill Patients: A Randomized Clinical Trial},
  journal = {Journal of Cellular and Molecular Anesthesia},
  year = {2024},
  doi = {10.5812/jcma-149015}
}
Kostenlos starten →